Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Pharmacol., 20 October 2025

Sec. Translational Pharmacology

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1721652

Correction: Drug interactions between cephalosporins and 5-FU-based chemotherapy in the treatment of patients with gastrointestinal cancer - an exploratory cohort analysis

This article is a correction to:

  1. Drug interactions between cephalosporins and 5-FU-based chemotherapy in the treatment of patients with gastrointestinal cancer - an exploratory cohort analysis

    1. Read original article
Robert SiegelRobert Siegel1Sophie Schlosser-HupfSophie Schlosser-Hupf2Martina Müller-SchillingMartina Müller-Schilling2Samer A. KharroubiSamer A. Kharroubi3Andr GessnerAndré Gessner1Nahed El-Najjar, Nahed El-Najjar1,4*
  • 1Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany
  • 2Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, Immunology, and Infectious Diseases, University Hospital Regensburg, Regensburg, Germany
  • 3Department of Nutrition and Food Sciences, Faculty of Agricultural and Food Sciences, American University of Beirut, Beirut, Lebanon
  • 4Department of Pharmacology and Toxicology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon

A Correction on
Drug interactions between cephalosporins and 5-FU-based chemotherapy in the treatment of patients with gastrointestinal cancer - an exploratory cohort analysis

by Siegel R, Schlosser-Hupf S, Müller-Schilling M, Kharroubi SA, Gessner A and El-Najjar N (2025). Front. Pharmacol. 16:1652957. doi: 10.3389/fphar.2025.1652957

Affiliation “Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany” was erroneously omitted for author Nahed El-Najjar.

The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: drug-drug interactions, cephalosporins, 5-fluorouracil, sepsis, oncology, adverse drug reactions

Citation: Siegel R, Schlosser-Hupf S, Müller-Schilling M, Kharroubi SA, Gessner A and El-Najjar N (2025) Correction: Drug interactions between cephalosporins and 5-FU-based chemotherapy in the treatment of patients with gastrointestinal cancer - an exploratory cohort analysis. Front. Pharmacol. 16:1721652. doi: 10.3389/fphar.2025.1721652

Received: 09 October 2025; Accepted: 10 October 2025;
Published: 20 October 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Siegel, Schlosser-Hupf, Müller-Schilling, Kharroubi, Gessner and El-Najjar. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Nahed El-Najjar, bmUwOUBhdWIuZWR1Lmxi

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.